Farfetch Limited (FTCH) delivered earnings and revenue surprises of 28.13% and 2.56%, respectively, for the quarter ended December 2021. Do the numbers hold clues to what lies ahead for the…
Author archives: Zacks Equity Research
Vapotherm (VAPO) Reports Q4 Loss, Tops Revenue Estimates
Vapotherm (VAPO) delivered earnings and revenue surprises of -14.52% and 2.04%, respectively, for the quarter ended December 2021. Do the numbers hold clues to what lies ahead for the stock?
Universal Health Services (UHS) Q4 Earnings and Revenues Top Estimates
Universal Health Services (UHS) delivered earnings and revenue surprises of 4.24% and 4.15%, respectively, for the quarter ended December 2021. Do the numbers hold clues to what lies ahead for…
UiPath (PATH) Gains But Lags Market: What You Should Know
UiPath (PATH) closed at $32.40 in the latest trading session, marking a +0.97% move from the prior day.
MetLife (MET) Offers Employers Aura’s Digital Security Solutions
MetLife (MET) forges an alliance with Aura to safeguard the digital identity of employees, having access to its U.S. Group Benefits platform, with the latter’s solutions.
Canadian Natural Resources (CNQ) Earnings Expected to Grow: What to Know Ahead of Next Week’s Release
Canadian Natural Resources (CNQ) doesn’t possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Earnings Preview: Big Lots (BIG) Q4 Earnings Expected to Decline
Big Lots (BIG) doesn’t possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Earnings Preview: Gap (GPS) Q4 Earnings Expected to Decline
Gap (GPS) doesn’t possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Profound Medical (PROF) May Report Negative Earnings: Know the Trend Ahead of Next Week’s Release
Profound Medical (PROF) doesn’t possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Veritone, Inc. (VERI) Earnings Expected to Grow: Should You Buy?
Veritone, Inc. (VERI) doesn’t possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.